Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.18 USD | +1.14% | +2.70% | +14.80% |
05-13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
05-10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |